Lenalidomid Labormed 25 mg tvrde kapsule קרואטיה - קרואטית - HALMED (Agencija za lijekove i medicinske proizvode)

lenalidomid labormed 25 mg tvrde kapsule

labormed - pharma s.a., 44b theodor pallady blvd, 3rd district, bucharest, rumunjska - lenalidomidum - kapsula, tvrda - 25 mg - urbroj: jedna kapsula sadrži 25 mg lenalidomida

Lenalidomid Labormed 5 mg tvrde kapsule קרואטיה - קרואטית - HALMED (Agencija za lijekove i medicinske proizvode)

lenalidomid labormed 5 mg tvrde kapsule

labormed - pharma s.a., 44b theodor pallady blvd, 3rd district, bucharest, rumunjska - lenalidomidum - kapsula, tvrda - 5 mg - urbroj: jedna kapsula sadrži 5 mg lenalidomida

Lenalidomid Labormed 7,5 mg tvrde kapsule קרואטיה - קרואטית - HALMED (Agencija za lijekove i medicinske proizvode)

lenalidomid labormed 7,5 mg tvrde kapsule

labormed - pharma s.a., 44b theodor pallady blvd, 3rd district, bucharest, rumunjska - lenalidomidum - kapsula, tvrda - 7,5 mg - urbroj: jedna kapsula sadrži 7,5 mg lenalidomida

Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) האיחוד האירופי - קרואטית - EMA (European Medicines Agency)

lenalidomide krka d.d. novo mesto (previously lenalidomide krka)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imunosupresivi - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).